Dr. Gemma Casadesus is working as an Core Director in Case Western Reserve University School of Medicine, USA.She has completed her Ph.D on Physiological Psychology from Tufts University. She has got patent rights for Amylin single or combined therapies for cognitive dysfunction and Alzheimer’s disease and Treatment of post-menopausal and post-hysterectomy mediated cognitive disorders. She is working as an editorial board member for many Journals. She has published more than 80 articles.

Neurosciences, Neuropathology

Dr. Hirani received his Ph.D. in Pharmacology from Nagpur University Department of Pharmaceutical Sciences, India and post-doctoral training at Department of Anatomy, University of South Florida before joining UHealth (University of Miami) as a clinical research pharmacist. Dr. Hirani contributed significantly to advance understanding of effects of psychiatric drugs through translational in-vivo models and advanced behavioral protocols. His areas of expertise include investigational medicinal products, pre-clinical behavioral testing in animal models, research pharmacy, trial data review, human subject protection and compliance assessment and safety pharmacology. He serves as a clinical co-investigator and a pharmacological expert across multiple boards and committees that oversee the pharmaceutical development process including data safety and monitoring, human ethics board, feasibility committee and editorial advisory boards to provide scientific direction. He is also a clinical scientist on studies that seek answers to specific questions about vaccines, new drugs, or new ways of using known treatments in the area of HIV/AIDS, psychiatric disorders and Oncology. His clinical research involvement aids in the necessary foundation for advancing pre-clinical and clinical pharmacology to pace promising therapies from the laboratory into the clinic for patient care.

Dr. Hirani’s major research interests and experience include mechanisms of novel pharmacological agents in the treatment of neuropsychiatric disorders, HIV/AIDS and advanced cancers

Chamindie Punyadeera, molecular biologist, graduated from department of Chemical Pathology, the University of Witwatersrand, Johannesburg, South Africa in 2001. Her PhD research was aimed at investigating the pathogenesis and clinical manifestation of type 2 Diabetes and obesity. She was also awarded the Academic Excellence Scholarship from the University of Witwatersrand. She did a 4-year postdoctoral fellowship at the University of Maastricht in close collaboration with Merck Pharmaceuticals. The research was focused on endometrium physiology, steroid hormone pharmacokinetics and oncology. She has published over 30 research papers, 15 PCT patents and has also reviewed papers and has delivered key note lectures. She has presented at major international conferences. She also worked at Philips Research High Tech Campus in the Netherlands as a senior scientist, and  led a project team on biosensor development and  biomarker discovery. Currently, she is leading a research group at the University of Queensland in Australia investigating the diagnostic potential of saliva and developing new technologies and tools to dissect out the biomolecules present in human saliva.
 

Molecular genetics, RNA Expression analysis, RNA isolation, Immunology, Biochemistry, Tissue Culture, Phage display,Protein expression, Epigenetics

Dr. Shahzad is currently affiliated with University of Vienna, Austria. Prof. Shahzad is one of the pioneers, working for the progress of translational medicine field. He is serving as a secretary general and director of administration for “international society for translational medicine (ISTM)” He is serving as visiting professor of translational medicine, at the First Affiliated Hospital, Harbin Medical University, Harbin, China. He is also appointed as associate professor of translational medicine (Adj), at the First Affiliated Hospital, Wenzhou Medical College, China. Prof. Shahzad has won many prestigious international fellowships and awards. Prof. Shahzad is invited speaker for many international life sciences conferences.
 

Translational Research and Molecular Diagnostics

Rebecca L. Cunningham is a research assistant professor in the Department of Pharmacology and Neuroscience at the University of North Texas Health Science Center in Fort Worth TX. She completed her B.S. in Psychology from Truman State University, Kirksville, MO in 2001 and received her Ph.D. in Biology with an emphasis on neurobiology from University of Texas at San Antonio, San Antonio, TX in 2006. Her postdoctoral training was completed in 2010 following two postdoctoral fellowships at University of Texas Health Science Center at San Antonio, TX and University of North Texas Health Science at Fort Worth, TX. She is a member of several organizations, such as American Physiological Society, Society for Neuroscience, Endocrine Society, and others. Recently, she received the Young Investigator Award by the American Physiological Society, Cell and Molecular Physiology Section. Her research has been focused on understanding the role of androgens and aging on dopaminergic neurodegeneration.

Androgen Action,
Calcium Signaling,
Aging,
Neurodegeneration,
Oxidative Stress,
Mitochondrial Function

Paul E Micevych is Professor of Neurobiology David Geffen School of Medicine at UCLA Professor of Surgery Division of Head Neck Surgery David Geffen School of Medicine at UCLA He completed a postdoctoral fellowship in the Dept of Neurologic Surgery Mayo Clinic Rochester MN He received a PhD from the Department of Anatomy University of Minnesota Minneapolis MN He completed a BA in Biology from the University of St Thomas St Paul MN He was a William Evans Fellow University of Otago Dunedin New Zealand He was a permanent member of the Neuroendocrinology Neuroimmunology and Behavior Study section and now is an ad hoc reviewer for NIH He served on the Neuroendocrinology Panel NSF He is on the editorial boards of three other journals and published over 155 articles chapters and reviews

Reproductive neuroendocrinology Neurosteroids: regulation of synthesis and physiology Membrane steroid receptors: regulation and intracellular signaling Steroid signaling in the brain G-protein receptors and receptor trafficking Chemical neuroanatomy Estradiol-induced plasticity Neurochemistry of female sexual receptivity Estrogen positive feedback: regulation of LH release and ovulation Sex steroid-mediated neuroprotection Sex difference in the brain.

Elizabeth M. Wilson, Ph.D., is Professor of Pediatrics and Biochemistry and Biophysics at the University of North Carolina at Chapel Hill. She has worked in the area of the androgen receptor for more than 20 years. Her research group cloned the androgen receptor complementary DNA in 1988 and later identified and characterized the androgen-dependent AR NH2- and carboxyl-terminal N/C interaction that has become the focus of drug discovery for selective androgen receptor modulators. More recently, melanoma antigen-A11 was identified and characterized as a primate-specific androgen receptor coregulator important in the mid-secretory endometrium and prostate cancer growth. Dr. Wilson′s research is funded by grants from NICHD and NCI of the NIH and the Department of Defense.

Androgen receptor

Dr. Anthony C. Hackney is Director of the Applied Physiology Laboratory in the Department of Exercise & Sport Science at the University of North Carolina, Chapel Hill North Carolina. He is Professor of Exercise Physiology, University of North Carolina, Professor of Nutrition, School of Public Health, University of North Carolina, Adjunct Professor of Allied Health, School of Medicine, University of North Carolina. He received a B.A. from Berea College, Kentucky; M.A. from Kent State University, Ohio; Ph.D. from Kent State University, Ohio, D.Sc. from National Academy of Physical Culture, Kaunas, Lithuania. He is a member of the editorial board of five journals and has published over 100 research articles.

Stress and the endocrine system Regulation of energy metabolism during exercise Endocrine dysfunction with exercise training

Dr. Cheryl Frye is behavioral neuroscientist and professor in the Department of Psychology. Dr. Frye is committed to her student′s intellectual and professional development and the award recognizes her superior work in advising and mentoring students. She provides rigorous training in research skills to a wide range of students, from those in high school to doctoral candidates. She regularly encourages her students to present their research at professional meetings and she was a founding member of N.E.U.R.O.N., the Northeast Undergraduate Research Organization in Neuroscience. Eight of her students have won University at Albany Presidential Awards for Undergraduate Research. Cheryl Frye recipient of Dean′s awards for outstanding achievement in teaching, 2009. Cheryl Frye was awarded the CAS Dean′s award for excellence in student mentoring.

The focus of my research program is determining how steroid hormones work in the brain and influence behavior (see press release). My research primarily has focused on non-traditional or "non-genomic" actions of steroid hormones (termed neurosteroids) and their role in mediating reproductive behavior in rodents. Because hormones are essential for mating, we have used reproductive behavior as an indication of the effectiveness of different experimental hormone manipulations. As diverse actions of steroidsmechanisms are revealed through our reproductive behavior experiments, we then examine the role of different actions of steroids on developmental processes (puberty, pregnancy, aging, etc) and in mediating behaviorally-relevant processes, such as anxiety, learning, neuroprotection, throughout the lifespan. As such, our research has made important contributions to understanding sex differences and the role of hormones in the etiology, exacerbation and/or treatment of many clinically-relevant conditions including depression, anxiety, schizophrenia, Alzheimers disease and epilepsy. My students and I are actively involved in the Northeast Undergraduate Research Organization in Neuroscience (NEURON). Specific research interests follow.

Mesut Muyan, DVM, PhD, is currently a Research Professor in the Departments of Biochemistry& Biophysics, Obstetric & Gynecology, and Oncology at the University of Rochester Medical School, Rochester-NY, USA. He obtained his DVM degree from the Ankara University, Ankara-Turkey. He earned his PhD at the University of California-Davis, Davis-California, USA. He has published in the area of Endocrinology and Molecular & Cellular Biology. He served as a reviewer of peer-reviewed journals covering molecular and cellular biology of signal transduction and pharmacogenetics. He is a member of AAAS, the Endocrine Society and NURSA.

Research interest is to understand the signaling mechanisms of steroid hormones in general and estrogens in particular. The dissection of hormone signaling pathways is critical for the elucidation of the relative importance of each pathway in physiology and pathophysiology of target tissue functions. A better conceptualization of regulatory mechanisms for hormone signaling also provides a basis for the development of novel therapeutic approaches for estrogen target tissue malignancies.

Dr. Mary Jane De Souza is working as a Professor in the Department of Kinesiology and Physiology, at the Pennsylvania State University University Park,  USA.

Womens health and Physical Activity, Endocrinology of the Female Athlete,Effects of Exercise on the Menstrual Cycle, Female Athlete Triad (Eating disorders, amenorrhea and osteoporosis), Eating Behaviors, Food Intake, and Exercise, Luteal Phase Defects and Amenorrhea, Bone Health and Osteoporosis in Female Athletes, and Energy Deficiency and Bone Health

Beverley Greenwood-Van Meerveld is the Director of the Oklahoma Center for Neuroscience, University of Oklahoma Health Sciences Center Professor of Physiology, University of Oklahoma Health Sciences Center Adjunct Professor, Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center VA Career Scientist She received a PhD in Philosophy from the University of Sheffield, UK 1983 She completed his BSc (Special Hons) in Physiology infrom the University of Sheffield, UK 1980 She received the Janssen Award for her basic research in digestive diseases in 2004 She has over 100 peer-reviewed articles, is serving as an editorial board member of reputed journals and reviews for multiple journals.

Dr. Beverley Greenwood-Van Meerveld′s research focuses on understanding the mechanisms by which glucocorticoids affect the expression of stress responsive genes in various brain regions that are critical for regulation of gastrointestinal sensitivity, motility and secretion. Dr. Greenwood-Van Meerveld′s research is also examining the mechanisms of corticoid receptor regulation and glucocorticoid regulation in response to early life trauma, aging and other stress-related disease states. Brain-Gut Interactions Effect of stress on the gastrointestinal motility, secretion and sensitivity. Role of amygdala activation on the gastrointestinal tract.

Sanjay Awasthi earned Medical degree in 1986 from University of Texas Southwestern Medical School in Dallas, Texas; internship and residency in internal medicine with the department of Internal Medicine, University of Arkansas Medical School in Little Rock, Arkansas 1986-1989; postgraduate fellowship in oncology from the Department of Hematology-Oncology at University of Texas Southwestern Medical School in Dallas, Texas 1989-1991. American Chemical Society, Texas Medical Association, American Medical Association, American Association for Cancer Research, Southwest Oncology Group and Association of Scientists of Indian Origin in America, American Society of Clinical Oncology, and the American Association of Cancer Research.

Sanjay Awasthi, M.D. specializes in medical oncology. He is board certified in internal medicine and medical oncology. His professional interests include breast cancer, hormone-resistant prostate cancer, lung cancer, colon cancer, and the use of antioxidants in cancer prevention.

Salman Azhar is a Professor in Department of Veterans Affairs Palo Alto Health Care System.He received his Ph.D. in 1973 at C.S.J.M. University, Kanpur. He is active member of many associations like The American Association for the Advancement of Science, The American Society for Biochemistry and Molecular Biology.

Gastroenterology, Hepatology, Endocrinology.

Dr. Jacques Bernier received his B.Sc. and M.Sc. in biology from the University du Quebec a Montreal. He then obtained Ph.D. degree in cellular biology from the faculty of medicine of the University de Sherbrooke. Following postdoctoral studies at the Institut de recherches cliniques de Montreal in molecular immunology, he joined the research center of Hôtel-Dieu de Montreal as independent researcher, working on the effect of burn injury on the immune response. In 1997 Dr. Bernier became professor at INRS-Armand Frappier Institute while keeping an affiliation as an associate researcher with the Burn Research Center at the Hôtel-Dieu de Montreal.

His background is on the immunomodulation induced either by a pathogen, a physical stress or a xenobiotic. He is working on the role of endocrine disruptors on the immune function.

Dr. Nahid Parvizi is working as a Professor in the Departmemt of Functional Genomics & Bioregulation Institute of Animal Genetics FLI, Mariensee, Germany.

Functional Genomics & Bioregulation

Dr. De Rossi received his DMD from the University of Pennsylvania School of Dental Medicine in 1995 and completed his post-doctoral training in Oral Medicine at the University of Pennsylvania Medical Center in 1998. Dr. De Rossi has had a clinical practice limited to Oral Mucosal Disease, Facial Pain and Salivary Gland Disease for the past 13 years. He achieved Diplomat Status from the American Board of Oral Medicine in 1999. Dr. De Rossi′s currently an Associate Professor of Oral Medicine and Chairman of Oral Health and Diagnostic Sciences at the Medical College of Georgia School of Dentistry and Associate Professor of Otolaryngology/Head and Neck Surgery and Associate Professor of Dermatology in the School of Medicine. He is serving as an Editorial Board Member of 7 Journals currently and has published over 75 manuscripts, abstracts and book chapters in the filed of Oral Medicine.

His research interests include oral complications of systemic disease and treatment, xerostomia , orofacial pain disorders, and the dental management of medically complex patients.

Jeffrey M. McBride is an Associate Professor in Biomechanics at Appalachian State University in the Department of Health, Leisure & Exercise Science. He is the Director of the Neuromuscular Laboratory and the Director of Graduate Studies in Exercise Science. He received his PhD in Human Movement from Southern Cross University in Australia. He completed his Master’s Degree in Exercise Physiology at Penn State and his Bachelor’s Degree in Exercise Science from West Virginia State University. He was awarded the Outstanding Young Investigator Award in 2006 from the National Strength & Conditioning Association. He is also a Fellow of this same organization. He is an associate editor for the Journal of Strength & Conditioning Research and the Biomechanics Section Editor for the Journal of Sport Science & Medicine.

Stretch-Shortening Cycle Function Muscle Strength & Power Resistance & Power Training Methods

Qi-Huang Zheng is an Associate Professor in the Department of Radiology and Imaging Sciences at Indiana University School of Medicine. He has received his B.S. (Chemistry, 1980-1984) and M.S. (Chemistry, 1984-1987) from Xiamen University, China, and Ph.D. (Chemistry, 1987-1990) from Zhongshan University, China. He has pursued his postdoctoral research first at University of Chicago (Chemistry, 1994), then at Indiana University Purdue University Indianapolis (Chemistry, 1994), and eventually at Indiana University (Radiochemistry, 1995-1997). He has received the China Young Chemist Prize in 1991; China Guangdong Province Science and Technology Progress Achievement Award in 1995; and Bioorganic & Medicinal Chemistry Letters Most Cited Paper 2006-2009 Award in 2009. He is serving as an abstract reviewer for the Society of Nuclear Medicine Annual Meeting, a manuscript reviewer for 33 scientific journals and a grant reviewer for 7 grant agencies/foundations. He has published over 250 research and review articles, meeting abstracts, and book chapters.

Design, synthesis and biological evaluation of new radiopharmaceuticals (tumor, brain and heart imaging agents) for use in the biomedical imaging technique positron emission tomography (PET) to study tumor, brain and heart diseases. Synthesis of anticancer drugs Radiosynthesis of cancer diagnostic agents Breast cancer detection and treatment Breast cancer PET imaging Synthesis and radiolabeling of steroids and non-steroidal analogues that are inhibitors of steroid biosynthetic enzymes or ligands for steroid hormone receptors.

Dr. James Charles Bigelow is an Associate Professor in the Department of Biomedicaland Pharmaceutical Science at Idaho State University, USA. He works in the field of Biomedical and Pharmaceutical Science. He did his Postdoctoral Researcher in the Department of Chemistry at University of Utah. He worked as a Director for Vermont Cancer Center HPLC Core Laboratory in the University of Vermont.
 

Biomedical and Pharmaceutical Science

Dr. Dongbao Chen is Associate Professor of Obstetrics & Gynecology and Experimental Pathology, and the Director of Perinatal Research at University of California Irvine. He received PhD in Reproductive Physiology from China Agricultural University (1991) and postdoctoral training at Baylor College of Medicine (1993-1995) and was a Lalor Fellow at University of Kansas School of Medicine (1995-1998). He was a Research Scientist at University of Wisconsin-Madison (1999-2001) and at University of California San Diego (2001-2003). He was Adjunct Assistant Professor (2003), Assistant Professor (2005), and Associate Professor with tenure (2007) at University of California San Diego. Dr. Chen’s research has been continuously funded by NHLBI, NICHD, AHA and private foundations since 2001. He serves on many grant review panels for National Institutes of Health, American Heart Association, and several international agencies. He is ad hoc reviewer of more than ten journals including JCEM, FRBM, AJP and BOR, etc.

His research interest is to elucidate the cellular and molecular mechanisms underlying steroid hormone and growth factor control of vascular tone and angiogenesis at the maternal, fetal and placental interface during pregnancy with focuses on reactive nitrogen and oxygen species.

Hiroshi Kanazawa is an Associate Professor of Department of Respiratory Medicine, Graduate School of Medicine, Osaka City University, Japan. He has received a PhD from Osaka City University in Japan in 1988-1992. He received 8 Medical Research Award from Japanese Respiratory Society, Japanese Society of Allergology, and several Japanese Societies for Promotion of Science. (Number of publications, Original article 120, Review article 22)

Steroid biology in respiratory medicine Oxidative stress in respiratory medicine Biomarkers of respiratory medicine Molecular biology of respiratory medicine Pathophysiology and management of bronchial asthma and COPD

Dr. Carlo Spirli works in the Department of Internal Medicine Section of Digestive Diseases in Yale University, USA. His main focus is on pathophysiology and therapy of diseases of the biliary tree. This is a large group of chronic liver diseases, congenital or acquired, that causes significant morbility and mortality in both the adult and pediatric population. The pathogenesis of biliary tree diseases is still elusive and, contrary to other areas of hepatology, effective treatment is still lacking. Previous work of our laboratory has contributed to the understanding of the normal physiology of biliary cells and to the identification of prototypic mechanisms for biliary damage for which a model human cholangiopathy exists. Among them, the lab is now addressing the pathophysiology and treatment of Cystic Fibrosis cholangiopathy, polycystic liver disease and Alagille syndrome.




 

The main focus of my research is the pathophysiology and therapy of diseases of the biliary tree (also called cholangiopathies). This is a large group of chronic liver diseases, congenital or acquired, that causes significant morbility and mortality in both the adult and pediatric population. The pathogenesis of biliary tree diseases is still elusive and, contrary to other areas of hepatology, effective treatment is still lacking. Previous work of our laboratory has contributed to the understanding of the normal physiology of biliary cells and to the identification of prototypic mechanisms for biliary damage for which a model human cholangiopathy exists. Among them, the lab is now addressing the pathophysiology and treatment of Cystic Fibrosis cholangiopathy, polycystic liver disease and Alagille syndrome.

Mingyue Liu, MD, PhD,is an Assistant Professor, and Director, APOM Laboratory Cell Models Training, Anesthesiology & Perioperative Medicine (APOM), Oregon Health & Science University School of Medicine, USA. She received her MD from Tianjin Medical University, China in 1989. She received her PhD in physiology and pharmacology from Hokkaido University School of Medicine, Japan in 2001. She is a member of American Heart Association/stroke council, Society for Neuroscience, American Physiological Society, and International Society for Cerebral Blood Flow and Metabolism. She is Ad hoc Reviewer of 7 reputed journals (Reviewer for Stroke, Journal of Neuroscience, Brain Research, Journal of Neuroscience Research, Open Neurology Journal, and Journal of Neurochemistry).

Neuroscience, stroke Molecular mechanisms and neuroprotection underlying sex differences in ischemic brain injury Sex differences in astrocytes, neurons and endothelial cell sensitivity to ischemia Effects of sex steroids on ischemic outcome Regulation of cerebrovascular and mechanisms after brain injury

Dr. Bryan O’Neil Boulanger works in Environmental & Water Resources Engineering Division, Zachry Department of Civil Engineering,Texas A&M University, USA. He has done his Ph.D from University of Iowa. His work is mostly related to Civil Engineering, Environmental & Water Resources, Water Management & Hydrologic Science.

 

Civil Engineering, Environmental & Water Resources, Water Management & Hydrologic Science.

Dr. Emma J. Coddington works in the Biology Department of Willamette University at USA

Endocrinology

D. Hunter Best is an assistant professor of pathology at the University of Utah School of Medicine and an assistant medical director of the molecular genetics laboratory at ARUP Laboratories, Inc., Salt Lake City, UT. He received his Ph.D. in Molecular and Cellular Pathology from the University of North Carolina at Chapel Hill, Chapel Hill, NC, in 2007 and his B.S. in Biochemistry from North Carolina State University, Raleigh, NC, in 2002. He received postdoctoral training at Vanderbilt University Medical Center in Nashville, TN and is board certified in Clinical Molecular Genetics by the American Board of Medical Genetics (ABMG). In 2008, he received the Association for Molecular Pathology (AMP) Young Investigator Award for research he conducted on somatic gene mutations observed in acute myeloid leukemia (AML) patients and their relationship to overall patient survival.

Somatic Alterations in Acute Leukemia The Genetics, Pathogenesis, and Treatment of Pulmonary Arterial Hyptersion (PAH) The Biology of Liver Stem-Like Cells The Role of Growth Factors in Liver Regeneration.

Dr. Joshua W. Gatson is currently working in the Department of Surgery, Division of Burns, Trauma and Critical Care at UT Southwestern Medical Center, USA. He has published many articles in the field of Critical Care

Critical Care

Dr.Igor Butovich is working in the Department of Ophthalmology,Graduate School of Biomedical Sciences at University of Texas, USA. He research work is related to the fields of enzymology, pharmaceutical Sciences and biochemistry

Enzymology, Pharmaceutical Sciences, Biochemistry

Ram Ramabhadran is the Acting Division Director of the Integrated Systems Toxicology Division (ISTD) of Environmental Protection Agency’s(EPA’s) National Health and Ecological Effects Laboratory (NHEERL). He obtained his Ph.D. in Molecular Biology from the University of Texas at Dallas (1975), followed by postdoctoral studies at the Washington University School of Medicine in St. Louis. He has held several positions in pharmaceutical and biotechnology companies. He holds adjunct faculty appointments at the Division of Neurology at the Duke University Medical Center and in the Curriculum in Toxicology at the University of North Carolina, Chapel Hill.

His research areas include endocrine hormones and their receptors, neuropeptides and their receptors, and development of assays for the interrogation of intracellular signaling pathways involved in hormone action. His current research is focused on methods for rapid identification of environmental toxicants.

Tomoshige Kino is a head of Unit on Molecular Hormone Action, Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. He has completed his B.A in Medicine in Chiba University, Chiba, Japan (1985). He received the Merck Senior Fellow Award from the Endocrine Society and 2 Merit Awards from Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. He is serving as an editorial board member of 2 reputed journals. He has currently 96 publications appeared in PUBMED, 16 book chapters and 1 book edition. Every year, he performs ~10-20 reviews requested by prestigious Journals.

Biomedical and Pharmaceutical Science

Dr. Ze-hua Liu is a research scientist in Department of Urban Engineering, Graduate School of Engineering, Osaka City University, Japan. He has received his B.S (Chemical Engineering, 1997-2001) from Xiangtan University, China, M.S (Biochemical Engineering, 2001-2004) from Beijing University of Chemical Engineering, China, and Ph.D (Urban Engineering, 2007.4-2010.3) from Osaka City University, Japan. For his excellent research during the doctoral study, he has been awarded as the 2009 National Award for Outstanding Self-financed Chinese Students Study Abroad by China Scholarship Council, for which no more than 500 Chinese students all over the world were selected at this year. He has published more than twenty peer-reviewed papers, among which two articles has been listed as the top 25 hottest articles in Science of the total environment. He is reviewers for several peer reviewed journals such as Science of the Total Environment, Environmental Science and Pollution Research, and Journal of Women’s Health.

Urinary estrogens/androgens/phytoestrogens Hormone level and health Biomonitoring such as estrogen (androgen)-receptor binding assay Monitoring of micropollutants Environmental pollution

Kamran Hosseini MD, PhD serves as Vice President of Clinical Affairs and Chief Medical Officer at InSite Vision Inc., where he oversees preclinical and clinical research. Dr. Hosseini is also a co-founder of KMG Pharma, an ophthalmic drug delivery specialty company. He was a Director of Ophthalmology at ALZA Corporation, a member of the Johnson & Johnson Family of Companies. While Dr. Hosseini′s main interest is in ocular drug delivery, his pioneering work with non-invasive drug monitoring in the eye using Raman Spectroscopy has won the highest award from the American Society for Laser Medicine and Surgery. Dr. Hosseini received his M.D. from the University of Groningen Faculty of Medicine, The Netherlands; and his Ph.D. as part of a joint program at the University of Texas, Medical Branch in Galveston and the University of Maastricht, The Netherlands. He completed a post doctoral fellowship at the University of California, San Francisco. Reviewer for 3 scientific journals. 35 + scientific papers and presentations.

Ocular Drug delivery Minimally invasive drug delivery Clinical Ophthalmology Steroidal and non-steroidal anti-inflammatory compounds Pharmaceutical Re-profiling Non-invasive drug monitoring in vivo

Marco Turatti is a neurologist and PhD student at the Department of Neurological, Psychological, Morphological and Motor Sciences, University of Verona, Italy. He has received his medical degree at the University of Ferrara, Italy, in 2003. He has completed his residency in Neurology at the University of Verona in 2008. He has been a Post-doctoral Fellow at the Multiple Sclerosis Center - Advanced Imaging in Multiple Sclerosis Group, University of California of San Francisco, USA, in 2006-2007. His PhD program in Neuroscience is focused on functional MRI in multiple sclerosis.

Clinical Neurology Clinical Neurophysiology Multiple sclerosis Magnetic resonance in MS Atypical forms of MS (lo toglierei)

Eugenia Makrantonaki is a medical doctor at the Departments of Dermatology, Allergology, Venereology and Immunology, in Dessau Medical Center (Dessau, Germany) and a research group leader in the Laboratory for Biogerontology, Dermato-Pharmacology and Dermato-Endocrinology, Institute of Clinical Pharmacology and Toxicology, Charité University Berlin, Campus Benjamin Franklin (Berlin, Germany). She holds a MD degree from the Aristoteles University (Thessaloniki, Greece) and a PhD in Medicine from Charité University Berlin. Recipient of the 3rd Tiburtius Prize of the Berlin Universities for the best dissertation, the Hermal Support Prize 2006- New concepts in diagnosis and treatment, the William Cunliffe Scientific Award 2006, the R.O.S.A. Prize (Research on Skin Dryness Award) 2008 and the Beauty Care Prize 2009 from the German Society of Dermatology for her contribution to the investigation of the molecular mechanisms involved in human skin aging. She is serving as a reviewer of reputed journals such as Experimental Dermatology, British Journal of Dermatology, Archives of Dermatology and Journal of the European Academy of Dermatology and Venereology. She has contributed with several publications and book chapters.

The use of skin as a model for understanding the pathogenesis of aging and age-associated diseases of internal organs. The study of the effects of circulating hormones on the generation of aging. siRNA technology Evaluation of the biological effects of skin cells after treatment with herbal extracts. Effects of hormones on skin barrier function. Induction of pluripotent cells from human skin cells. Investigation of tumor cells obtained from M. Recklinghausen patients.

Dr. Elisabeth Barbier is currently working in the School of Pharmacy Pharmaceutical Sciences at University of Maryland,USA

Pharmaceutical Sciences

Dr. Farage Miranda is working currently in Feminine Clinical Sciences, The Procter & Gamble Company, USA. Recently, increased awareness for the need to critically look at the vulva tissue differently has been emphasized in several of her publications and review articles published in peer-reviewed journals and books.

Dr. Farage currently leads research on vulvology, dermatological testing, emotional and invention of new clinical method developments. She is particularly interested in advancing research and technical understanding on vulva skin, health; life time changes, skin effects, sensitivity and different skin exposure physiological impact.  In addition, Dr. Farage’s research is also focused on the sub-clinical, Quality of Life and sensory effects. Dr. Farage led the need to change the traditional approach and thinking in the safety assessments and exposure estimates for the genital skin.  Recently, increased awareness for the need to critically look at the vulva tissue differently has been emphasized in several of her publications and review articles published in peer-reviewed journals and books.

Dr. Maddalena Barba is working in the department of Epidemiology, National Cancer Institute Regina Elena Rome, Italy

Epidemiology

Dr. Dustin Yates is working in the Department of Animal Sciences at University of Arizona,USA. He has published many articles in the field of Physiology.

Physiology

Dr. Serena Vettori is presently working at Piazza della Meridiana, Italy. Apart from her work she is mostly interested in the field of Endocrynology.

Endocrynology

Dr. Popescu Marius-Constantin is working in the department of Faculty of Electrical Engineering at University of Craiova, Romania.He has published many atrticles in the field of Electrical Engineering
 

Electrical Engineering

Dr. Weidong Han was born in 1969 in Shanxi province, China. In 1990, he obtained his BS degree in clinical medicine from Changzhi Medical College. He obtained his master degree in clinical hematology in 1998 from Shanxi Medical College. In 2001, he obtained his Ph.D degree in clinical hematology from Chinese PLA Postgraduate Medical School. Subsequently, he worked in Institute of Basic Medicine, Chinese PLA General Hospital. In 2006, he was promoted to associate professor of tumor biology and cell biology. In 2003, he did postdoctoral work at the University College London. Now, he is the director of department of molecular and cellular biology, Director of Clinical Translational Ward, the General Hospital of PLA. Since 2001, he focused on research of hormone-related cancers. He has published over 20 articles. Now, he established a medical translational ward in General Hospital of PLA for clinical research.
 

Hormone-related cancer, Cellular reprogramming, Clinical translation

Dr. Juan Ding received her B.S. degree from Tsinghua University, Beijing, China in 2004. She then studied in the Molecular and Cellular Biology program under the supervision of Dr. John Kopchick at Ohio University and received her Ph.D. in 2009. Her Ph.D. dissertation unraveled biomarkers of growth hormone and aging in a series of mouse models that showed excess or disrupted growth hormone signaling. As a post doctoral research associate, Dr. Ding focused on detecting growth hormone doping and discovered novel biomarkers of recombinant human growth hormone administration in healthy human subjects. Dr. Ding has published many original research articles as well as reviews and a book chapter on growth hormone, aging, proteomics and molecular biology. Currently Dr. Ding is working at Schepens Eye Research Institute at Harvard medical school to unravel the endocrine regulation of meibomian gland in dry eye disease.

Dr. Ding is interested in the endocrine regulation of aging and age-related diseases. Her current research focuses on dry eye disease, which affects 3 million Americans and is more prevalent among the elderly. Specifically, Dr. Ding is interested in unraveling the molecular mechanism of the pathophysiology induced by retinoic acid, with the objective of identifying therapeutic targets to treat dry eye disease.

Ajay Singh, Ph.D., is an Assistant Professor of Oncologic Sciences at University of South Alabama Mitchell Cancer Institute (USAMCI). Dr. Singh received a Master’s degree in Biotechnology from Aligarh Muslim University and graduated from the Devi Ahilya University, Indore, India. He completed a short post-doctoral fellowship in the Department of Biochemistry and Molecular Biology at University of Nebraska Medical Center, Omaha, Nebraska. He later attained a research faculty position in the same department, and joined USAMCI in 2009 as a tenure-track faculty. Studies in Dr. Singh’s laboratory have been supported through state and federal grants. He was awarded funds from State of Nebraska for two consecutive years (2007 and 2008) and one grant each from National Cancer Institute (NCI) and Department of Defense (DOD) to support his research. Dr. Singh serves on regional, national and international panels to review research proposals for funding considerations.

Dr. Singh’s research is to delineate the molecular mechanisms underlying the aggressive and therapy-resistant behavior of cancer cells. In particular, his lab is investigating the role of microRNAs and tumor microenvironment in facilitating growth, epithelial to mesenchymal transition (EMT), metastasis and drug-resistance of pancreatic and prostate tumor cells. Earlier studies of Dr. Singh identified a mucin gene, MUC4, to be of pathological significance in pancreatic cancer progression and metastasis. MUC4 is an aberrantly expressed glycoprotein in pancreatic cancer exhibiting no expression in the normal pancreas. Recently, his team identified a novel microRNA-mediated mechanism involved in its deregulation in pancreatic cancer. Dr. Singh’s research has also revealed that CXCL12-CXCR4 signaling axis, an exemplary of tumor-microenvironment interaction, promotes drug-resistance in pancreatic cancer cells. In additional studies, his group has identified protein phosphatase 2A (PP2A) as a novel therapeutic target in prostate cancer. They have shown that PP2A activity is inversely associated with androgen-independent growth of prostate cancer cells through a novel mechanism, whereby loss of PP2A-mediated checkpoints leads to the activation of Akt and ERK and partially sustains androgen receptor signaling under steroid-deprived condition. The findings from Dr. Singh’s lab offer potential therapeutic implications for microRNAs, PP2A and tumor-microenvironment in highly aggressive and therapy-resistant pancreatic and/or prostate malignancies

He is an Associate Professor and Surgeon in the Department of Otorhinolaryngology – Head & Neck Surgery in Universiti Sains Malaysia.  He  held a number of professional posts in the national level over the years. He has published and presented in many scientific papers, both at the national and international level. He is also actively involved in services to many international professional communities as invited speakers and presenters. To date, he has organized more than 20 conferences with roles and responsibilities from organizing committee to organizing chairperson. He has contributed significantly to the successes of symposiums and workshops in my University and the Malaysian Society of Otorhinolaryngologists-Head and Neck Surgeons (MSO-HNS) Meetings.

Head Neck Medicine, Thyroid Disorders.
 

Jeroen Declercq is a senior postdoc at the Laboratory of Biochemical Neuroendocrinology, department of Human Genetic, Catholic University Leuven, Belgium. He did his undergraduate work at the Catholic university of Leuven, where he obtained a master of Biochemistry. He completed a second Master of Immunology, signaling transduction and lymphomas at the University Paul Sabatier, Toulouse, France. He was a PhD student at the Laboratory of Molecular Oncology at the Catholic University of Leuven, doing doctoral work with Prof. Wim J.M. Van de Ven. He performed a first postdoctoral training in the Stem Cell Institute Leuven, under the guidance of Prof. Catherine Verfaillie. Currently he works on “Protein biosynthesis, maturation and traffic in the (regulated) secretory signaling pathway, related to human diseases” in the Laboratory of Prof. John. W.M Creemers.

Immunology, Signaling transduction, Lymphomas, Protein biosynthesis, Molecular Oncology

Dr. Shao is currently an associate professor in the Institute of Neuroscience and Physiology, The Sahlgrenska Academy at Gothenburg University, Sweden. Dr. Shao trained as a cellular and molecular biologist and received his PhD in 2005 from Gothenburg University. The focus of Dr. Shao’s current research is focusing on investigation of the molecular aetiology of tubal ectopic pregnancy including the interaction between signals derived from the Fallopian tube and endometrium for blastocyst implantation and the role of nuclear receptor signalling. Research is also being focused on the dynamics of reproductive systems, how these are influenced by environmental factors, and links with metabolism and disease risk in humans. He has published 29 scientific papers and been peer reviewer for 16 scientific journals

Nuclear receptor signaling, Neuroscience, Physiology

Yousef Rasmi,is an Clinical biochemist involved in both teaching and research at Department of Biochemistry, Urmia University of Medical Sciences (UMSU), Urmia, Iran.In PhD courses he worked on evaluation of GST and COX-2 expression in reflux and esophagus cancer. The major research interest understands the link between Helicobacter pylori infection, inflammation, endothelial dysfunction and microvascular/ macrovascular disease e.g. diabetes mellitus, syndrome metabolic, cardiac syndrome X and cancer. Besides helping other groups students working on oxidative stress status in experimental animals. He is also, working in editorial boards of a few journals
 

Inflammation, Endothelial dysfunction, Diabetes mellitus, Syndrome metabolic, Cardiac syndrome X, Cancer

Dr Hosam A. Elbaz has received his PhD in West Virginia University during the period of 2007 -2011. Currently, he is working as a postdoctoral fellow Wayne State University School of Medicine. He is serving as an editorial member of Journal of Bioengineering and Biomedical Sciences and Journal of Nanomedicine and Nanotechnology. He is a member of American Society of Pharmacology and Experimental Therapeutics (ASPET), American Association of Pharmaceutical Scientists (AAPS), American Chemical Society (ACS), Egyptian General Syndicate of Pharmacists, and Golden Key International Honor Society.

Cancer Therapeutics
Carcinogenesis
Cell Cycle and Checkpoint Regulation
Apoptosis
Nanomedicine and Nanobiotechnology
Targeted Drug Delivery
Therapeutic Gene Delivery
Biochemical Pharmacology and Toxicology

Dr. Pandey received his Ph.D. from Lucknow University, Lucknow, India in 2005 in the area of Biochemistry. He has multidisciplinary research experience and is an author of several papers in the field of Endocrinology, hormones and aging in international top peer reviewed medical journals including Endocrinology, journal of Endocrinology, journal of Nutritional biochemistry and Gastroenterology, Journal of Leukocyte Biology and Enzyme and Microbial Technology.  He has attended several scientific meetings, national and international conferences. Dr. Pandey was awarded by the President of Endocrine Society at 90th annual international conference of the Endocrine Society; San Francisco, California-USA for his research work on hormones and male aging entitled "An Autocrine Loop Involved in Cyclooxygenase-2-Dependent Inhibition of Steroidogenic Acute Regulatory Gene Expression in MA-10 Mouse Leydig Cells". Presently, he has been working on identifying mechanisms relating to Cyclooxygenase-2-Dependent male aging and possibilities for its reversal via induction of StAR (Steroidogenic Acute Regulatory) gene expression using natural substances found in food (flavanoides) to improve the health of aging males and to explore the possibility of delaying their aging process.

His research work focuses on natural food flavanoides, their antioxidative properties and their protective roles in mitochondrial dysfunction in age related neurodegenerative diseases.